Research ArticleDrug Discovery and Translational Medicine
Selective prostacyclin receptor agonist selexipag, in contrast to prostacyclin analogs, does not evoke paradoxical vasoconstriction of rat femoral artery
Keith Morrison, Franck Haag, Roland Ernst, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics March 27, 2018, jpet.117.246058; DOI: https://doi.org/10.1124/jpet.117.246058
Keith Morrison
Idorsia Pharmaceuticals Ltd
Franck Haag
Idorsia Pharmaceuticals Ltd
Roland Ernst
Idorsia Pharmaceuticals Ltd
Marc Iglarz
Idorsia Pharmaceuticals Ltd
Martine Clozel
Idorsia Pharmaceuticals Ltd
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
Selective prostacyclin receptor agonist selexipag, in contrast to prostacyclin analogs, does not evoke paradoxical vasoconstriction of rat femoral artery
Keith Morrison, Franck Haag, Roland Ernst, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics March 27, 2018, jpet.117.246058; DOI: https://doi.org/10.1124/jpet.117.246058
Research ArticleDrug Discovery and Translational Medicine
Selective prostacyclin receptor agonist selexipag, in contrast to prostacyclin analogs, does not evoke paradoxical vasoconstriction of rat femoral artery
Keith Morrison, Franck Haag, Roland Ernst, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics March 27, 2018, jpet.117.246058; DOI: https://doi.org/10.1124/jpet.117.246058
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement